5 Recruiting Anemia Phase 2 Clinical Trials
Active phase 2 studies for anemia enrolling across the USA. Verify eligibility and contact site coordinators.
All Anemia studiesPhase 2 Studies for Anemia
🔵 Active, Not Recruiting Phase1 / Phase2
INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII.
📍 University Health Network (UHN) — Toronto, Ontario
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
📍 Local Institution - 0008 — Halifax, Nova Scotia
View Study & Checklist ➔ 🟢 Recruiting Phase2
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of Luspatercept in People With Anemia
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔